Kai Gastl
- Address
- Römerstraße 49, 82205 Gilching, Germany
Kai Gastl - Pain Management & Therapeutic Research
Kai Gastl specializes in clinical research evaluating topical and oral therapeutic interventions across multiple medical conditions. The center demonstrates expertise in acute musculoskeletal injury management and psychiatric disorders, conducting rigorous efficacy and safety assessments of both conventional and herbal medicinal products.
- Acute musculoskeletal injuries including ankle sprains and soft tissue contusions with topical pain management systems
- Respiratory conditions, particularly acute bronchitis, with comparative herbal medicine trials
- Psychiatric disorders including mild to moderate major depressive disorder with natural therapeutic agents
- Pharmaceutical formulation studies including patch adhesion and delivery system optimization
The research center conducts both randomized controlled trials and open-label studies, with particular focus on Esflurbiprofen Topical System (EFTS) for pain management and Silexan® for depressive disorders. The center employs validated outcome measures including Visual Analogue Scale (VAS) for pain assessment, Bronchitis Severity Score (BSS) for respiratory conditions, and Montgomery-Åsberg Depression Rating Scale (MADRS) for psychiatric evaluations, demonstrating comprehensive expertise in multi-center clinical trial methodology across diverse therapeutic areas.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Teikoku Seiyaku Co. Ltd.3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Kai Gastl
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Comparison of Herbal Medicinal Products in Acute Bronchitis: Liquid Extract from Thyme Herb, Primrose Root Tincture, and Ivy Leaf Extract | Engelhard Arzneimittel GmbH & Co. KG | Phase III | Not Recruiting | Feb 2024 | Apr 2024 |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Esflurbiprofen | 3 | Unknown | 2023-09-14 | 2025-03-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.